This inventor holds 7 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, The Simons Center for Systems Biology at the Institute for Advanced Study. Active years: 2010-2025.
Location History:
- New York, NY (US) (2010 - 2022)
- Cortlandt Manor, NY (US) (2021 - 2022)
Company Filing History:
5 out of 618 
1 out of 535 
1 out of 1 Years Active: 2010-2025
Title: The Innovative Contributions of Timothy A Chan
Introduction
Timothy A Chan is a prominent inventor based in New York, NY, known for his significant contributions to cancer research and immunotherapy. With a total of six patents to his name, Chan has made strides in understanding and treating cancer through innovative methodologies.
Latest Patents
One of Chan's latest patents focuses on "Neoantigens and uses thereof for treating cancer." This patent outlines systems and methods for determining the likely responsiveness of a human cancer subject to a checkpoint blockade immunotherapy regimen. The process involves obtaining sequencing reads from cancer samples, determining human leukocyte antigen types, and computing clone fitness scores based on neoantigens. Another notable patent describes "Determinants of cancer response to immunotherapy," which details molecular determinants and tools for identifying cancers likely to respond to such treatments.
Career Highlights
Chan has worked at the prestigious Memorial Sloan Kettering Cancer Center, where he has contributed to groundbreaking research in cancer treatment. His work has been instrumental in advancing the field of immunotherapy, providing new insights into how cancers can be effectively targeted and treated.
Collaborations
Throughout his career, Chan has collaborated with notable colleagues, including Marta Luksza and Vinod P Balachandran. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in cancer therapies.
Conclusion
Timothy A Chan's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patents and research contributions continue to pave the way for advancements in immunotherapy, showcasing the vital role of inventors in the medical field.